Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Amantadine use during acute hospitalization for neurological recovery after stroke: a systematic review

1 month 3 weeks ago
CONCLUSIONS: The evidence supporting amantadine use during acute hospitalization for stroke is limited and heterogeneous. While amantadine is commonly used to promote arousal in patients with impaired consciousness after stroke, available data do not allow firm conclusions regarding efficacy for functional recovery or mortality, and safety conclusions remain limited by inconsistent adverse-event reporting. Prospective, stroke-specific studies conducted in the acute hospital setting are needed to...
Andrea Loggini

Impact of intravenous thrombolysis on aspiration thrombectomy outcomes: an Imperative Trial subgroup analysis

1 month 3 weeks ago
CONCLUSIONS: Aspiration thrombectomy alone may result in higher rates of successful reperfusion and reduce the need for rescue devices compared with the combined approach with IV thrombolysis.
Maxim Mokin

Comparative Risk of Adverse Cardiovascular Outcomes with Zanubrutinib vs Ibrutinib in B-Cell Malignancies: A Large Real-World Propensity-Matched Analysis

1 month 3 weeks ago
CONCLUSION: Zanubrutinib was associated with a lower risk of AF/AFL, major bleeding, and all-cause mortality compared with Ibrutinib. These findings support the preferential use of Zanubrutinib when cardiovascular safety is a key consideration in patients with B-cell malignancies.
Usama Qamar

Evaluating pain management strategies following hypospadias repair: a survey of pediatric urologists

1 month 3 weeks ago
CONCLUSIONS: This study demonstrates wide variability in opioid prescribing patterns and attitudes among pediatric urologists. Despite growing evidence that opioids may not be necessary following pediatric urologic surgery, over half of pediatric urologists regularly prescribe opioids following hypospadias repair. Additionally, over half of the respondents believe opioids are over-prescribed. These findings represent an opportunity to improve opioid stewardship, which is meaningful given the...
Jaisa Kaufmann

Prophylactic Left Atrial Appendage Occlusion During Mitral Valve Repair in Patients Without Atral Fibrillation: A Meta-Analysis of Time to Event Data

1 month 3 weeks ago
CONCLUSIONS: Prophylactic LAAO during MVr in patients without AF may reduce thromboembolic events risk but appears to increase postoperative AF. Further randomized studies are warranted.
Ahmed Emara

Pagination

  • Previous page ‹ Previous
  • Page 113
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies